Scerra, Gianluca (2023) A suboptimal signal peptide defines spatiotemporal control of PD-L1 expression. [Tesi di dottorato]

[thumbnail of scerra_gianluca_35_COMPLETO.pdf] Testo
scerra_gianluca_35_COMPLETO.pdf
Visibile a [TBR] Amministratori dell'archivio

Download (2MB) | Richiedi una copia
[thumbnail of scerra_gianluca_35_PARZIALE.pdf]
Anteprima
Testo
scerra_gianluca_35_PARZIALE.pdf

Download (1MB) | Anteprima
Tipologia del documento: Tesi di dottorato
Lingua: English
Titolo: A suboptimal signal peptide defines spatiotemporal control of PD-L1 expression
Autori:
Autore
Email
Scerra, Gianluca
gianluca.scerra@unina.it
Data: 9 Marzo 2023
Numero di pagine: 69
Istituzione: Università degli Studi di Napoli Federico II
Dipartimento: Medicina Molecolare e Biotecnologie Mediche
Dottorato: Medicina molecolare e biotecnologie mediche
Ciclo di dottorato: 35
Coordinatore del Corso di dottorato:
nome
email
Santoro, Massimo
massimo.santoro@unina.it
Tutor:
nome
email
Renna, Maurizio
[non definito]
D'Agostino, Massimo
[non definito]
Data: 9 Marzo 2023
Numero di pagine: 69
Parole chiave: PD-L1; signal peptide; cytoRUSH; translocation
Settori scientifico-disciplinari del MIUR: Area 05 - Scienze biologiche > BIO/13 - Biologia applicata
Depositato il: 21 Mar 2023 10:30
Ultima modifica: 10 Apr 2025 14:05
URI: http://www.fedoa.unina.it/id/eprint/15160

Abstract

Malignant cells exploit the expression of the programmed death-1 (PD-1)-ligand 1 (PD-L1) to avoid T-cell-mediated immunosurveillance and promote tumor survival and expansion. Post-translational modifications have emerged as important regulatory mechanisms to modulate PD-L1 expression on the cell surface of cancer cells. However, spatiotemporal control of such modifications is still poorly understood. Here we show that amino-terminal signal peptide plays a major role in dictating the right temporal window for post-translational modifications. Particularly, we have developed the cytosolic version of the retention using selective hook assay (cytoRUSH) to demonstrate that the signal peptide of PD-L1 is suboptimal for the endoplasmic reticulum translocation and introduces a lagging time for pre-translocational modifications acquisition. Accordingly, PD-L1 equipped with an optimized signal peptide variant was insensitive to AMPK-dependent post-translational modifications relevant for driving PD-L1 down-modulation by the proteasome. Moreover, this variant renders PD-L1 defective in trafficking, maturation, and localization to the plasma membrane thereby confirming the physiological relevance of the lagging time introduced by its own signal peptide. In conclusion, these findings suggest that a less efficient kinetic of translocation into the endoplasmic reticulum represents the key step for PD-L1 protein modulation by post-translational modifications acquisition and open intriguing future perspectives for pharmacological applications based on PD-L1 signal peptide targeting in cancer therapy.

Downloads

Downloads per month over past year

Actions (login required)

Modifica documento Modifica documento